Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Stufano

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Human Vaccines & Immunotherapeutics|October 21, 2022
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccineesFrancesca Dapporto, Margherita Leonardi, Claudia Maria Trombetta, et al.
Communications Biology|September 2, 2022
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinationsClaudia Maria Trombetta, Giulia Piccini, Giulio Pierleoni, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 16, 2026
Serum peripherin as a disease biomarker in hereditary transthyretin amyloidosis: a multicenter cohort studyDomenico Plantone, Delia Righi, Angela Romano, et al.
Journal of Neurology|April 15, 2025
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stagesDomenico Plantone, Marco Luigetti, Carlo Manco, et al.
Blood|July 19, 2021
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike proteinAndreas Greinacher, Kathleen Selleng, Julia Mayerle, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Human Vaccines & Immunotherapeutics|October 21, 2022
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccineesFrancesca Dapporto, Margherita Leonardi, Claudia Maria Trombetta, et al.
Communications Biology|September 2, 2022
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinationsClaudia Maria Trombetta, Giulia Piccini, Giulio Pierleoni, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 16, 2026
Serum peripherin as a disease biomarker in hereditary transthyretin amyloidosis: a multicenter cohort studyDomenico Plantone, Delia Righi, Angela Romano, et al.
Journal of Neurology|April 15, 2025
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stagesDomenico Plantone, Marco Luigetti, Carlo Manco, et al.
Blood|July 19, 2021
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike proteinAndreas Greinacher, Kathleen Selleng, Julia Mayerle, et al.
Pageof 7